Credit Suisse Ag Veracyte, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Veracyte, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 95,773 shares of VCYT stock, worth $3.94 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

95,773

Previous 95,767 0.01%

Holding current value

$3.94 Million

Previous $2.63 Million 19.44%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$21.0 - $29.1 $126 - $174	6 Added 0.01%	95,773 $2.12 Million
Q4 2023 Feb 08, 2024	BUY	$19.72 - $28.68 $85,170 - $123,868	4,319 Added 4.72%	95,767 $2.63 Million
Q3 2023 Nov 13, 2023	SELL	$22.33 - $29.92 $237,323 - $317,989	-10,628 Reduced 10.41%	91,448 $2.04 Million
Q2 2023 Aug 11, 2023	BUY	$20.96 - $26.99 $459,506 - $591,701	21,923 Added 27.35%	102,076 $2.6 Million
Q1 2023 May 10, 2023	BUY	$20.58 - $27.89 $47,272 - $64,063	2,297 Added 2.95%	80,153 $1.79 Million
Q4 2022 Feb 13, 2023	BUY	$15.31 - $29.94 $58,790 - $114,969	3,840 Added 5.19%	77,856 $1.85 Million
Q3 2022 Nov 10, 2022	BUY	$16.58 - $27.9 $7,527 - $12,666	454 Added 0.62%	74,016 $1.23 Million
Q2 2022 Aug 12, 2022	SELL	$15.45 - $29.52 $78,285 - $149,577	-5,067 Reduced 6.44%	73,562 $1.46 Million
Q1 2022 May 16, 2022	BUY	$21.94 - $42.51 $104,631 - $202,730	4,769 Added 6.46%	78,629 $2.17 Million
Q4 2021 Feb 14, 2022	BUY	$36.09 - $53.79 $176,299 - $262,764	4,885 Added 7.08%	73,860 $3.04 Million
Q3 2021 Nov 12, 2021	BUY	$35.62 - $52.97 $180,664 - $268,663	5,072 Added 7.94%	68,975 $3.2 Million
Q2 2021 Aug 16, 2021	BUY	$32.94 - $56.62 $174,450 - $299,859	5,296 Added 9.04%	63,903 $2.56 Million
Q1 2021 May 14, 2021	SELL	$44.47 - $81.38 $1.71 Million - $3.12 Million	-38,387 Reduced 39.58%	58,607 $3.15 Million
Q4 2020 Feb 12, 2021	BUY	$32.49 - $61.88 $568,607 - $1.08 Million	17,501 Added 22.02%	96,994 $4.75 Million
Q3 2020 Nov 13, 2020	SELL	$26.73 - $35.67 $1.4 Million - $1.87 Million	-52,420 Reduced 39.74%	79,493 $2.58 Million
Q2 2020 Aug 12, 2020	BUY	$19.49 - $28.11 $671,196 - $968,052	34,438 Added 35.33%	131,913 $3.42 Million
Q1 2020 May 13, 2020	SELL	$16.13 - $30.17 $443,478 - $829,493	-27,494 Reduced 22.0%	97,475 $2.37 Million
Q4 2019 Feb 12, 2020	BUY	$20.78 - $29.99 $322,775 - $465,834	15,533 Added 14.19%	124,969 $3.49 Million
Q3 2019 Nov 12, 2019	SELL	$23.87 - $30.93 $634,727 - $822,459	-26,591 Reduced 19.55%	109,436 $2.63 Million
Q2 2019 Aug 14, 2019	BUY	$22.1 - $28.56 $3.01 Million - $3.88 Million	136,027 New	136,027 $3.88 Million
Q2 2018 Aug 14, 2018	SELL	$5.39 - $9.66 $58,535 - $104,907	-10,860 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$5.44 - $6.97 $59,078 - $75,694	10,860 New	10,860 $60,000
Q4 2017 Feb 14, 2018	SELL	$6.05 - $9.37 $96,890 - $150,060	-16,015 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$7.81 - $8.77 $125,077 - $140,451	16,015	16,015 $141,000

Others Institutions Holding VCYT

# of Institutions

308

Shares Held

81.8M

Call Options Held

134K

Put Options Held

13.3K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.94B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account